Roundtable. Blueprint for conversion of patients on metformin and sulfonylurea to Glucovance.
Roselli
A
A
Hayes
J D
JD
Seidner
R
R
Marchione
V
V
Snyder
C M
CM
Mayes
K
K
Stiernberg
C M
CM
Milgram
L
L
D003376:Counseling; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D004338:Drug Combinations; D004359:Drug Therapy, Combination; D005905:Glyburide / Q000008:administration & dosage*; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage*; D008687:Metformin / Q000008:administration & dosage*; D010349:Patient Compliance; D010353:Patient Education as Topic / Q000379:methods*; D013453:Sulfonylurea Compounds / Q000008:administration & dosage*; D014481:United States
D004338:Drug Combinations; C417231:Glucovance; D007004:Hypoglycemic Agents; D013453:Sulfonylurea Compounds; D008687:Metformin; D005905:Glyburide